Home/Rithim Biologics/Ronald L. Anderson
RL

Ronald L. Anderson

Co-Founder, President, Chief Executive Officer, Chairman of the Board

Rithim Biologics

Rithim Biologics Pipeline

DrugIndicationPhase
Gene Therapy for Atrial TachyarrhythmiasFast heart rates originating in the atria (e.g., Atrial Fibrillation)Pre-clinical
Gene Therapy for Ventricular TachyarrhythmiasFast heart rates originating in the ventriclesPre-clinical